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Stellingen behorende bij het proefschrift getiteld: 
Tailored dosimetry in the radioiodine treatment of  
differentiated thyroid cancer 
Roel Wierts, 30 mei 2018 
1. 124I PET-based dosimetry provides valuable prognostic information 
regarding lesion response to radioiodine treatment in differentiated 
thyroid cancer (This thesis, valorization). 
2. A personalized radioiodine therapy approach is most beneficial for 
differentiated thyroid cancer patients presenting with metastatic 
disease (This thesis, chapter 3). 
3. Prompt gamma coincidence correction improves the accuracy of lesion 
dosimetry in 124I PET imaging (This thesis, chapter 4). 
4. Accurate quantitative 124I PET/MRI-based lesion dosimetry is feasible in 
differentiated thyroid cancer (This thesis, chapter 5). 
5. Ceiling scatter should be considered in the radiation shielding 
calculations of nuclear medicine rooms (This thesis, chapter 6). 
6. Reliable patient dosimetry is a keystone of high quality radionuclide 
therapy (Hubert Thierens) 
7. The full power of personalized radionuclide therapy is yet to be 
unleashed. 
8. Nuclear medicine is more than the comprehensive extension to 
radiology.  
9. Eén keer is ook periodiek (Anne Paans). 
